Cargando…

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions

BACKGROUND: The aim of the present study was to assess the influence of anemia on the risk of developing contrast-induced nephropathy after percutaneous coronary angioplasty. METHODS: Serum creatinine values were measured before and within 48 h after the administration of contrast agents. Contrast-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wen-hua, Li, Dong-ye, Han, Fei, Xu, Tong-da, Zhang, Yang-bing, Zhu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2012
Materias:	Nephrology - Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732774/ https://www.ncbi.nlm.nih.gov/pubmed/23225080 http://dx.doi.org/10.1007/s11255-012-0340-8

Ejemplares similares

Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention
por: Chen, Hanchuan, et al.
Publicado: (2021)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
por: Xu, Zhongchi, et al.
Publicado: (2022)

Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis
por: He, Huan, et al.
Publicado: (2019)

Characterization of patients with IgA nephropathy with and without associated minimal change disease
por: Guo, Wei-yi, et al.
Publicado: (2023)

Chronic Nephropathy from Dietary Hyperoxaluria: Sustained Improvement of Renal Function after Dietary Intervention
por: Sun, Yijuan, et al.
Publicado: (2017)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019)

An Inconspicuous Offender: Apixaban-Induced Anticoagulant-Related Nephropathy
por: Shaw, Dylan J, et al.
Publicado: (2023)

Lupus nephropathy beyond immunosuppression: Searching for nephro and cardioprotection
por: Morales, Enrique, et al.
Publicado: (2023)

Treatment of membranous nephropathy: Perspectives on current and future therapies
por: Shah, Monarch, et al.
Publicado: (2023)

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014)

Bile Cast Nephropathy Secondary to Hemophagocytic Lymphohistiocytosis With Liver Failure
por: Chango Azanza, Juan Jose, et al.
Publicado: (2020)

IgA nephropathy: a review of existing and emerging therapies
por: Noor, Sahibzadi Mahrukh, et al.
Publicado: (2023)

Preprocedural N‐Terminal Pro‐Brain Natriuretic Peptide (NT‐proBNP) Is Similar to the Mehran Contrast‐Induced Nephropathy (CIN) Score in Predicting CIN Following Elective Coronary Angiography
por: Liu, Yong, et al.
Publicado: (2015)

Anticoagulant-Related Nephropathy: A Common, Under-Diagnosed Clinical Entity
por: Afiari, Agura, et al.
Publicado: (2022)

Safety and Effectiveness of Roxadustat in Dialysis-Dependent Patients With Renal Anemia: A Hospital-Based Cohort Study
por: Moussa, Oumarou, et al.
Publicado: (2022)

Urethral Amyloidosis in a Patient with IgA Nephropathy After Renal Transplant
por: Ojile, Nicholas, et al.
Publicado: (2017)

A Case Report of Generalized Pustular Psoriasis Associated With IgA Nephropathy
por: Klimko, Artsiom, et al.
Publicado: (2020)

Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
por: HE, HAIYAN, et al.
Publicado: (2014)

Risk factors of contrast-induced nephropathy in patients with STEMI and pump failure undergoing percutaneous coronary intervention
por: Chen, Hongwu, et al.
Publicado: (2021)

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2014)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhu, Boqian, et al.
Publicado: (2016)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
por: Zhang, H., et al.
Publicado: (2021)

Magnetic resonance diffusion tensor imaging applied to rat model of contrast-induced acute kidney injury
por: Wang, Bin, et al.
Publicado: (2021)

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties
por: Cepaityte, Dainora, et al.
Publicado: (2023)

Case Report: Efficacy of albumin dialysis for the reversal of bile cast nephropathy-induced acute kidney injury
por: Issac, Aaron G., et al.
Publicado: (2023)

Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zuo, Pengfei, et al.
Publicado: (2020)

Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
por: Jacquot, Laetitia, et al.
Publicado: (2023)

The Cost-Effectiveness of Using Epoetin-Beta Versus Darbepoetin-Alfa for the Treatment of Anemia Among Chronic Hemodialysis Patients
por: AlKharboush, Hanan, et al.
Publicado: (2020)

Non-invasive intradialytic percutaneous perfusion monitoring: a view to the heart through the skin
por: Penny, Jarrin D., et al.
Publicado: (2023)

Hypokalemic Nephropathy
por: Yalamanchili, Hima Bindu, et al.
Publicado: (2018)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions
por: Chiang, Chia-Hung, et al.
Publicado: (2014)

Lysozyme-Induced Nephropathy
por: Santoriello, Dominick, et al.
Publicado: (2016)

Hemoglobin Cast Nephropathy
por: Mahmud, Saqib, et al.
Publicado: (2020)

Impact of Exercise on Fatigue in Patients Undergoing Dialysis in a Tertiary Care Hospital
por: Samuel Raj V, Vijay, et al.
Publicado: (2023)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
por: Sinha, Shubhadeep D, et al.
Publicado: (2021)

Periprocedural Hemoglobin Drop and Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients
por: Lee, Kang Hyu, et al.
Publicado: (2010)

Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention
por: Demirkol, Sait, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sm7e459dic07l5gserb2i86pd1